April 2025

Monthly Archives

Latest stories

More stories

  • Revolutionary combination drug increases survival rate for advanced lung cancer patients with EGFR mutation

    Amivantamab-Lazertinib Leads to Improved Progression-Free Survival in EGFR-Mutated Advanced NSCLC Non-small cell lung cancer (NSCLC) is a type of cancer that affects the lungs and is responsible for most lung cancer cases. EGFR-mutated advanced NSCLC is a subtype of NSCLC that can be challenging to treat. However, a recent phase 3 trial has shown that […] More

  • Nervogen Pro Reviews – Honest Customer Feedback Unleashed!

    Nervogen Pro: A Natural Approach to Managing Nerve Pain? Nerve pain, also known as neuropathy, can be a constant source of discomfort and can significantly disrupt daily life. Many people seek relief from various treatments and medications but find that not all of these solutions work well for them. This led to the development of […] More

  • Ann Wilson Reveals Cancer Diagnosis Postpones Heart Tour

    Rock and Roll Hall of Famer Ann Wilson Taking Time Off for Cancer Treatment Heart Lead Singer Announces Cancer Diagnosis Ann Wilson, lead singer of the iconic rock band Heart, has revealed she has cancer and will be stepping back from performing to undergo treatment. The 74-year-old musician shared the news with her fans in […] More

  • TikTok Executive Diagnosed Stage 4 Cancer at 38

    TikTok Executive Diagnosed with Stage 4 Non-Hodgkin’s Lymphoma It is shocking to learn that even those who live a healthy and active lifestyle are not immune to serious illnesses such as cancer. This was the case for Govind Sandu, the head of TikTok Australia’s Global Music Partnerships, who recently shared on Instagram that he has […] More

  • Projected Ibuprofen Market Worth Over USD 200 Million by 2033

    The Ibuprofen Market: Opportunities and Challenges The growing trend of self-medication has resulted in a significant expansion of the over-the-counter (OTC) market, particularly for pain relief medications like Ibuprofen. According to a recent report by Market.us Media, the Ibuprofen market is poised for significant growth, with a projected valuation of approximately USD 205.6 million by […] More

  • Target discovered for the treatment of pancreatic cancer

    Target Discovered for Pancreatic Cancer Treatment The Discovery A recent study from Kiel University identified RUVBL1 as a key player in the function of the tumor-causing protein MYC. MYC genes are responsible for the majority of cancer development in humans, making it an essential target for cancer treatment research. However, to date, no clinical applications […] More

  • Deep and Durable Responses Ide-Cel CAR T Shows Promise for High-Risk Multiple

    Study Shows Promising Results in Treating High-Risk Multiple Myeloma with Ide-cel A cohort study of the KarMMa-2 trial discovered promising and durable responses in patients with high-risk multiple myeloma treated with ide-cel. The Study Results The overall response rate (ORR) in those who had a response but were treated in the frontline setting was 80.6% […] More

  • Impact of Coronary Artery Disease Patterns on Immediate PCI Results – Physician’s Weekly

    Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes Introduction Coronary artery disease (CAD) is a common cardiovascular disorder that affects millions of people worldwide. Percutaneous coronary intervention (PCI) is an established treatment for CAD. However, the safety and efficacy of PCI may be affected by the presence of diffuse […] More

  • Genentech Releases Exciting Press Releases on July 3, 2024

    Phase II/III SKYSCRAPER-06 study evaluating tiragolumab plus Tecentriq and chemotherapy did not meet primary endpoints Overview Genentech, a member of the Roche Group, announced that the Phase II/III SKYSCRAPER-06 study evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free survival and overall survival for people with previously untreated, locally advanced […] More

  • “Daily Multivitamin Use: No Benefit, Says Science-Based Medicine”

    Do Multivitamins Help or Harm Your Health? According to a new study published in JAMA Network Open by Erikka Loftfield and researchers at the National Institutes of Health’s National Cancer Institute, daily multivitamin use is associated with a higher mortality risk compared to non-users. This massive study with over 390,000 adults showed that there is […] More